Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-036

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 72205-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

Packaging label for Decitabine for Injection 50 mg per vial, sterile powder for intravenous infusion only. Includes warnings of cytotoxic agent and single-dose vial instructions. Labeler is Novadoz Pharmaceuticals LLC. The label provides reconstitution, storage, and handling directions along with barcode and manufacturer details.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of decitabine, illustrating the nucleoside analog's molecular framework with nitrogenous base and sugar moieties.*

FDA Label Image

Vial Label

Label for Decitabine for Injection 50 mg per vial, a lyophilized powder for intravenous solution by Novadoz Pharmaceuticals LLC. The label includes storage instructions, a cytotoxic agent warning, manufacturing details from MSN Laboratories Private Limited, India, and distribution details including a contact phone number. The label features dosage and single-dose vial usage instructions, along with an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.